Aim Vaccine Co. Ltd. (6660)

Overview

AIM Vaccine Co., Ltd. is a prominent entity in the pharmaceutical industry, primarily focused on the research and development, manufacturing, and distribution of vaccines for human application across the People's Republic of China. Having undergone a name change from Beijing AIM Biological Vaccine Technology Group Co., Ltd. to AIM Vaccine Co., Ltd. in September 2020, the company has been operational since 2011 with its headquarters nestled in Beijing. This organization plays a crucial role in responding to global and local health challenges by providing a diverse portfolio of vaccine products, aimed at combating a broad spectrum of infectious diseases.

Products and Services

• Bivalent Delta-Omicron BA.5 mRNA and Monovalent Omicron BA.5 mRNA Vaccines: These state-of-the-art mRNA vaccines, currently in phase III clinical trials, are designed for the prevention and treatment of COVID-19, showcasing the company's commitment to addressing the ongoing pandemic.
• EV71-CA16 Bivalent Vaccine for HFMD: Focused on Hand, Foot, and Mouth Disease (HFMD), this vaccine aims to protect against enterovirus 71 and coxsackievirus A16, which are common causative agents of the disease.
• Valent Pneumococcal Conjugate and Polysaccharide Vaccine: This vaccine is targeted towards preventing pneumococcal disease, responsible for causing pneumonia, meningitis, and sepsis among other conditions.
• Hexavalent Group B Streptococcus Polysaccharide Conjugate Vaccine: Aimed at combating Group B streptococcal disease, this hexavalent vaccine is a significant development for newborn and adult health.
• Diphtheria, Tetanus, and Pertussis (DTP) Vaccines: Including combinations with Haemophilus Influenzae type B (Hib), these vaccines are critical for the prevention of several bacterial diseases in children.
• Freeze-dried Human Rabies and mRNA Human Rabies Vaccine: These vaccines provide crucial protection against rabies, a deadly virus transmitted through the bites of infected animals.
• Human Papillomavirus (HPV) 2 and 3-valent Vaccine: Protecting against HPV, these vaccines aim to prevent cervical and other types of cancers caused by the virus.
• Tetravalent Meningococcal Conjugate Vaccine: This vaccine is vital for shielding individuals from meningitis and bloodstream infections caused by Neisseria meningitidis.
• Tetravalent Influenza Vaccine: Designed to protect against four influenza viruses, this vaccine is essential for mitigating the severity of seasonal flu outbreaks.
• mRNA Shingles/Herpes Zoster Vaccine: This advanced mRNA vaccine provides protection against shingles, a painful rash that can occur in anyone who has had chickenpox.
• mRNA Respiratory Syncytial Virus (RSV) Vaccine: Aimed at preventing RSV, a major cause of respiratory illness in infants and elderly adults.
• Live Attenuated Parotitis Vaccine: Offering protection against mumps, a contagious disease that can lead to serious health issues.
• ACYW135 Meningococcal Polysaccharide Vaccine: This vaccine is designed to protect against four types of Neisseria meningitidis, which can cause meningitis and septicemia.